Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Preliminary Efficacy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06477471
What this trial is testing

A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic. Supplementation in Reducing the Risk of Kidney Stone in Adults With Recurrent Kidney Stone Colic or Acute Episode of Colicky Pain.

Who this might be right for
Recurrent Kidney Stones With Colicky Pain
NovoBliss Research Pvt Ltd 14
Not applicableUnknownNCT05517187
What this trial is testing

Efficacy of Regenerative Endodontic Treatment With PRF as a Secondary Treatment of Mature Necrotic Incisors in Adolescents

Who this might be right for
Dental Pulp Necroses
Nahda University 40
Very early researchLooking for participantsNCT07574346
What this trial is testing

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Who this might be right for
Malignancies
Peking University People's Hospital 18
Early research (Phase 1)Not Yet RecruitingNCT06737146
What this trial is testing

Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma

Who this might be right for
High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT07413042
What this trial is testing

A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

Who this might be right for
SCLC, Extensive Stage
Peking University Cancer Hospital & Institute 24
Very early researchLooking for participantsNCT07556653
What this trial is testing

Allogeneic WTX-212C in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Zhejiang Provincial People's Hospital 24
Testing effectiveness (Phase 2)Study completedNCT05052567
What this trial is testing

CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Qilu Pharmaceutical Co., Ltd. 50
Very early researchStudy completedNCT06884111
What this trial is testing

Safety and Preliminary Efficacy Study of EE001 in Health/Patients Adults with Mild, Moderate, or Severe (NYHA II-IV) Cardiac Insufficiency

Who this might be right for
Cardiac Insufficiency
Anhui HygeianCells BioMedical Co., Ltd. 6
Testing effectiveness (Phase 2)UnknownNCT05986981
What this trial is testing

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Who this might be right for
Solid Tumor, Adult
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07432022
What this trial is testing

A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Combination TherapyAggressive B-Cell Non-Hodgkin LymphomaEMB07+1 more
Shanghai EpimAb Biotherapeutics Co., Ltd. 115
Not applicableStudy completedNCT06901037
What this trial is testing

A Pilot Randomized Controlled Trial of Chatbot Use in Older Adults for Lifestyle Change

Who this might be right for
Healthy Lifestyle
The Hong Kong Polytechnic University 50
Testing effectiveness (Phase 2)Study completedNCT03867253
What this trial is testing

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Oryzon Genomics S.A. 24
Testing effectiveness (Phase 2)Study completedNCT00076375
What this trial is testing

Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)

Who this might be right for
Atopic DermatitisEczema
Nucryst Pharmaceuticals 180
Very early researchNot Yet RecruitingNCT07583030
What this trial is testing

A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)Progressive Multiple Sclerosis (PMS)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 44
Early research (Phase 1)WithdrawnNCT05099536
What this trial is testing

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
3D Medicines (Beijing) Co., Ltd.
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Early research (Phase 1)Study completedNCT00910728
What this trial is testing

Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases

Who this might be right for
Primary Myelofibrosis (PMF)Post-Polycythaemia VeraEssential Thrombocythaemia Myelofibrosis
AstraZeneca 65
Early research (Phase 1)Study completedNCT02508467
What this trial is testing

Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Blueprint Medicines Corporation 146
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Early research (Phase 1)Not Yet RecruitingNCT07596381
What this trial is testing

FAK Inhibitor in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
InxMed (Shanghai) Co., Ltd. 75
Next Page